Clodronate
From Wikipedia, the free encyclopedia
 |
|
|
Clodronate
|
|
| Systematic (IUPAC) name | |
| (dichloro-phosphono-methyl)phosphonic acid | |
| Identifiers | |
| CAS number | |
| ATC code | M05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | CH4Cl2O6P2 |
| Mol. mass | 244.892 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Clodronate is a bisphosphonate. It is used in experimental medicine to selectively deplete for Macrophages. It is also approved for human use in Canada, where it is marketed as Bonefos and prescribed as a bone resorption inhibitor and antihypercalcemic agent.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
